Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Publication year range
1.
J Comput Assist Tomogr ; 35(2): 240-5, 2011.
Article in English | MEDLINE | ID: mdl-21412097

ABSTRACT

OBJECTIVES: Cystatin C (CyC) has recently been recognized as a sensitive marker for potential renal dysfunction. We investigated the role of CyC for evaluating potential kidney injury after computed tomography coronary angiography (CTCA). METHODS: The CyC, serum creatinine (sCr), estimated glomerular filtration rate (eGFR), and blood urea nitrogen (BUN) levels were evaluated before and 1 day and 1 week after the procedure in 140 patients with preserved renal function referred for CTCA. The amount of unrestricted oral fluid intake was measured for 24 hours after CTCA. The relationship between the amount of oral fluid intake and the changes in each renal marker was compared. RESULTS: A strong correlation was observed between oral fluid volume and the changes in CyC (r = -0.80, P < 0.0001) as well as the changes in sCr (r = -0.54, P < 0.0001) and eGFR (r = 0.57, P < 0.0001), but a weak correlation was observed between oral fluid volume and the changes in BUN (r = -0.22, P = 0.03). A progressive rise in a mean level of CyC was observed. The percentage of diabetic history was greater (73% vs 40%, P < 0.001) and oral fluid volume was lower (1142 mL vs 2114 mL, P < 0.0001) in patients with a rise in CyC but without one in sCr than in those showing a rise in neither CyC nor sCr at 1 day postprocedure. Seventy-four (80%) of 92 patients with a rise in CyC at 1 day postprocedure showed a recovery to the baseline sCr levels at 1 week postprocedure, but only 26 (28%) showed a recovery to the baseline CyC levels at 1 week. CONCLUSIONS: Cystatin C is a more sensitive marker than sCr in evaluating the effects of oral fluid volume on renal function and in detecting potential kidney injury, especially in diabetic patients after CTCA.


Subject(s)
Acute Kidney Injury/blood , Acute Kidney Injury/chemically induced , Coronary Angiography/adverse effects , Cystatin C/blood , Iothalamic Acid/adverse effects , Tomography, X-Ray Computed/adverse effects , Acute Kidney Injury/diagnosis , Adult , Biomarkers/blood , Contrast Media/adverse effects , Feasibility Studies , Female , Humans , Male , Middle Aged , Reproducibility of Results , Sensitivity and Specificity
2.
Circ J ; 73(7): 1324-9, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19423948

ABSTRACT

BACKGROUND: Endothelial progenitor cells (EPCs) have been assumed to maintain vascular endothelial integrity, so the present study investigated whether the functional capacity of EPCs correlates with endothelial function in healthy young subjects, as has been confirmed in aged subjects with atherosclerotic disease. METHODS AND RESULTS: EPCs in 41 healthy, young male nonsmokers (age 33.1 +/-3.9 years, mean +/- SD) were characterized. The correlation between flow-mediated vasodilation (FMD) and the number of EPCs or the plasma concentrations of growth factors, such as vascular endothelial growth factor, did not reach statistical significance. However, FMD was significantly correlated with the EPC differentiation index, defined as the ratio of the number of EPCs to the total number of adherent cells (r=0.391, P=0.011) and the abundance of endothelial nitric oxide synthase mRNA (r=0.340, P=0.030). CONCLUSIONS: In healthy young men, despite a lack of correlation of the number or colony counts of EPCs, the ability of circulating progenitor cells to differentiate into an endothelial lineage is closely correlated with endothelial function. This cell function assay may serve as a novel biomarker for vascular function in healthy subjects in the pre-atherosclerotic stage.


Subject(s)
Cell Differentiation , Endothelium, Vascular/cytology , Endothelium, Vascular/physiology , Mesenchymal Stem Cells/cytology , Adult , Biomarkers , Cell Proliferation , Cells, Cultured , Glucose/metabolism , Humans , Lipid Metabolism/physiology , Male , Mesenchymal Stem Cells/metabolism , Nitric Oxide Synthase/metabolism , RNA, Messenger/metabolism , Vasodilation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL